Your browser doesn't support javascript.
loading
Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus.
Liang, Matthew H; Simard, Julia F; Costenbader, Karen; Dore, Benjamin T; Ward, Michael; Fortin, Paul R; Illei, Gabor G; Manzi, Susan; Mittleman, Barbara; Buyon, Jill; Gupta, Samardeep; Abrahamowicz, Michal.
Affiliation
  • Liang MH; Department of Medicine, Brigham and Women's Hospital. MLIANG@PARTNERS.ORG
Endocr Metab Immune Disord Drug Targets ; 9(1): 108-12, 2009 Mar.
Article in En | MEDLINE | ID: mdl-19275685
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Erythematosus, Systemic Type of study: Prognostic_studies Limits: Humans Language: En Journal: Endocr Metab Immune Disord Drug Targets Journal subject: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Year: 2009 Document type: Article Country of publication: United Arab Emirates
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Erythematosus, Systemic Type of study: Prognostic_studies Limits: Humans Language: En Journal: Endocr Metab Immune Disord Drug Targets Journal subject: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Year: 2009 Document type: Article Country of publication: United Arab Emirates